The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhat, N.
Right arrow Articles by Vogel, S. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhat, N.
Right arrow Articles by Vogel, S. N.
The Journal of Immunology, 1999, 162: 7335-7342.
Copyright © 1999 by The American Association of Immunologists

Use of a Photoactivatable Taxol Analogue to Identify Unique Cellular Targets in Murine Macrophages: Identification of Murine CD18 as a Major Taxol-Binding Protein and a Role for Mac-1 in Taxol-Induced Gene Expression1

Nayantara Bhat2,*, Pin-Yu Perera2,*, Joan M. Carboni{dagger}, Jorge Blanco*, Douglas T. Golenbock{ddagger}, Tanya N. Mayadas§ and Stefanie N. Vogel3,*

* Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814; {dagger} Oncology Drug Discovery, Bristol-Myers Squibb, Princeton, NJ 08543; {ddagger} The Maxwell Finland Laboratory for Infectious Diseases, Boston University School of Medicine, Boston, MA 02118; and § Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Taxol, a potent antitumor agent that binds ß-tubulin and promotes microtubule assembly, results in mitotic arrest at the G2/M phase of the cell cycle. More recently, Taxol was shown to be a potent LPS mimetic in murine, but not in human macrophages, stimulating signaling pathways and gene expression indistinguishably from LPS. Although structurally unrelated to LPS, Taxol’s LPS-mimetic activities are blocked by inactive structural analogues of LPS, indicating that despite the species-restricted effects of Taxol, LPS and Taxol share a common receptor/signaling complex that might be important in LPS-induced human diseases. To identify components of the putatively shared Taxol/LPS receptor, a novel, photoactivatable Taxol analogue was employed to identify unique Taxol-binding proteins in murine macrophage membranes. Seven major Taxol-binding proteins, ranging from ~50 to 200 kDa, were detected. Although photoactivatable Taxol analogue failed to bind to CD14, the prominent Taxol-binding protein was identified as CD18, the ~96-kDa common component of the ß2 integrin family. This finding was supported by the concomitant failure of macrophage membranes from Mac-1 knockout mice to express immunoreactive CD18 and the major Taxol-binding protein. In addition, Taxol-induced IL-12 p40 mRNA was markedly reduced in Mac-1 knockout macrophages and anti-Mac-1 Ab blocked secretion of IL-12 p70 in Taxol- and LPS-stimulated macrophages. Since CD18 has been described as a participant in LPS-induced binding and signal transduction, these data support the hypothesis that the interaction of murine CD18 with Taxol is involved in its proinflammatory activity.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The antitumor drug, Taxol, binds with high affinity to ß-tubulin in microtubules, which, in turn, stabilizes polymerized microtubules, thus preventing mitosis (reviewed in Refs. 1 and 2). In 1990, Ding et al. (3) found that Taxol also elicited in murine macrophages two responses that are also strongly induced by Gram-negative LPS: TNF secretion and rapid involution of TNF receptors. These LPS-mimetic effects were observed only in mouse macrophages that expressed a normal Lps gene (Lpsn), and not in macrophages from LPS-hyporesponsive (Lpsd) mice (4). Over the next few years, Taxol was shown to mimic LPS effects on mouse macrophages with respect to activation of Lyn kinase activity (5), tyrosine phosphorylation of Shc and its association with Grb 2 (6), tyrosine phosphorylation of mitogen-activated protein kinases (7, 8, 9, 10), translocation of NF-{kappa}B (11, 12), and induction of gene expression (7, 8). Like LPS, Taxol can serve as a second signal for synergistic induction of inducible nitric oxide synthase mRNA and nitric oxide release, and tumoricidal and microbicidal activities in IFN-{gamma}-primed macrophages (13, 14). A clear dissociation has been shown between Taxol’s LPS-mimetic effects on macrophage signaling versus its microtubule-stabilizing effects in vitro and in cells. Taxol analogues, such as Taxotere and Epothilone, possess higher affinities for ß-tubulin than Taxol, compete with Taxol for the same binding site on microtubules, yet fail to elicit LPS-mimetic activity in murine macrophages (7, 15, 16, 17, 18, 19). Conversely, Taxol induces normal microtubule bundling in C3H/HeJ macrophages in the absence of detectable LPS-like signaling (7).

Taxol’s LPS-mimetic activity was not blocked by polymyxin B (15), an antibiotic that binds and inactivates LPS (20); however, lipid A analogue antagonists were inhibitory, suggesting that LPS and Taxol might engage elements within a shared receptor/signaling complex (15). Conversely, these same lipid A structural antagonists failed to inhibit Taxol-induced microtubule polymerization in macrophages (15), again suggesting that the shared signaling element is not ß-tubulin. Macrophages express a number of surface molecules (e.g., CD14, CD11/CD18, and others) that can interact with LPS (reviewed in 21). Studies using macrophages from CD14 knockout mice have shown that Taxol and LPS elicit gene expression by both CD14-dependent and independent pathways (22), suggesting the involvement of other receptors. Finally, the ability of Taxol to stimulate macrophages in an LPS-like fashion is species dependent (2), demonstrable in murine, but not in human macrophages; notably, the lipid A precursor, lipid IVA, shows a similar pattern of species specificity (reviewed in 16). Although the proinflammatory effects of Taxol are largely limited to murine cells, identification of components of the murine Taxol-signaling apparatus is likely to lead to the identification of homologous human LPS-signaling proteins.

To identify novel Taxol-binding proteins within a shared LPS signaling complex, we developed a novel detection system based on a photoactivatable Taxol analogue (PA Taxol) used originally to define Taxol’s interaction with tubulin (23). PA Taxol binds to at least seven murine macrophage membrane proteins, and the most prominent of these is the common component of the ß2 family of integrins, CD18, based on the coordinate failure of macrophages from Mac-1 knockout mice to express CD18 or the major ~96-kDa Taxol-binding protein. In contrast, CD14 is not a Taxol-binding protein. Finally, Taxol-induced IL-12 p40 mRNA was markedly reduced in macrophages derived from Mac-1 knockout mice, and anti-Mac-1 Ab blocks Taxol-induced IL-12 p70 secretion, suggesting that the interaction of Taxol with CD18 is critical for its ability to act as a full LPS mimetic.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice

Five- to seven-week-old C3H/OuJ or C3H/HeJ mice were obtained from The Jackson Laboratory (Bar Harbor, ME). CD11b (Mac-1) knockout (-/-) mice and wild-type (+/+) controls (24) were bred at Longwood Medical Research Center (Boston, MA). Mac-1 knockout and background-matched, wild-type colonies are of a mixed C57BL/129Sv background that is maintained by ongoing heterozygous breedings. Mice were housed in a virus Ab-free facility.

Preparation of cell membrane fractions

Peritoneal exudate cells (~85% macrophages) were collected by lavage with sterile saline 4 days after i.p. injection of mice with 3 ml thioglycollate (Difco, Detroit, MI). Cells were centrifuged (750 x g for 5 min) and resuspended in PBS (1x, pH 7.4). Cell viability was >95% by trypan blue exclusion. Peritoneal exudate cells were recentrifuged (750 x g, 5 min), and the pellet was resuspended at 1 x 107 cells/ml in homogenization buffer containing 25 mM HEPES, pH 7.3, 0.5 mM EGTA, 0.5 mM sodium orthovanadate, 0.1 mM sodium molybdate, 1 mM sodium fluoride, and protease inhibitors (1 tablet Complete (Boehringer Mannheim, Mannheim, Germany) per 50 ml buffer). A total of 7 ml of cell homogenate was incubated on ice, and cells were lysed using a tight-fitting dounce homogenizer (100 strokes). Unlysed cells, nuclei, and cell fragments (25) were removed by centrifugation (1000 x g, 10 min) at 4°C. The resulting nuclei-free supernatant was centrifuged again (10,000 x g, 7 min) at 4°C to remove aggregates of cytoskeletal elements (26). The membrane pellet was collected by a final centrifugation of the above supernatant at 417,000 x g (rav) for 2 h at 4°C and resuspended and solubilized in homogenization buffer containing 10 mM CHAPS (Sigma, St. Louis, MO). This membrane preparation method is a modification of that reported by Liu et al. (27). Protein determinations were performed by Bio-Rad protein assay (Richmond, CA). In some experiments, after UV cross-linking (below), 50 µl samples were centrifuged (20,800 x g, 15 min at 4°C) before Western analysis. Membranes were also prepared from the following cell lines: ST2 (a CD14-negative murine bone marrow-derived stromal cell line) (28, 29); CHO/Neo, CHO/murine CD14 (SAM8), and CHO/human CD11b-human CD18 cell lines were derived by stable transfection of Chinese hamster ovary (CHO)4 cell fibroblasts (30, 31).

UV-induced cross-linking of PA Taxol to membrane proteins

A 5-azido-2-nitrobenzoic acid C-7 photoaffinity analogue of Taxol (PA Taxol; m.w. = 1043) has been described (23). Multiwell plates (Falcon 96-well microtiter plates; Becton Dickinson, Lincoln Park, NJ) were prewetted with 50 µl of 50 mM Tris-HCl buffer, pH 7.4, and drained. Typically, a mixture containing 150 µg membrane protein and 6 µl PA Taxol (835 µM) was prepared in a final volume of 50 µl in 50 mM Tris-HCl buffer, pH 7.4, such that the final concentration of PA Taxol was 100 µM. Aliquots (50 µl) of this mixture were added to each well of the prewetted plate and incubated at 37°C (6% CO2) for 20 min. The plate was set on ice and UV irradiated at 4°C for 30 min with a mineral light lamp (model R52G; Ultraviolet Products, San Gabriel, CA; 0.16 A) at 254 nm at a distance of 7 cm, as described elsewhere (32). After irradiation, samples were diluted in 4x Laemmli buffer (32) (200 mM Tris-HCl, pH 6.8; 8% SDS; 400 mM DTT; 40% glycerol; 0.4% bromophenol blue; final concentration of Laemmli buffer is 1x) and boiled for 5 min. Membrane proteins (30–50 µg) were resolved by SDS-PAGE (typically, 9 or 10% acrylamide) under reducing conditions (33) (Mini Protean II; Bio-Rad, Hercules, CA). Prestained m.w. markers (low range; Bio-Rad) and unstained m.w. markers (wide range, Mark 12; Novex, San Diego, CA) were included in each gel.

Western blot analysis

Western blot analysis was utilized to detect Taxol-bound proteins, as well as to identify other proteins in membranes. For detection of CD18 by Western blotting, nonreducing conditions were required: samples were prepared for SDS-PAGE as described above in the absence of DTT. Following SDS-PAGE, resolved proteins were transferred to Immobilon-P membranes (Millipore, Bedford, MA) using a Minitrans Blot Electrophoretic Transfer Cell (Bio-Rad) for 1 h at 100 V at 4°C in transfer buffer (25 mM Tris, 192 mM glycine, pH 8.3, and 20% methanol). Blots were stained for 10 min in Ponceau S (Sigma) and destained in water. The positions of stained bands of authentic standards were used to calculate m.w. of separated proteins. Membranes were blocked for 1 h at room temperature in PBS containing 1% gelatin and 5% nonfat milk. After washing (3 times, 5 min each) with PBS, membranes were incubated with primary Ab diluted in PBS plus 5% nonfat milk for 1 h at room temperature. Membranes were washed (3 times, 10 min each) with PBS + Tween (0.05%) (PBST). Finally, membranes were incubated in an appropriate HRP-conjugated secondary Ab (i.e., goat anti-rabbit IgG (Bio-Rad), 1/2500; goat anti-mouse IgG (Bio-Rad), 1/5000; or goat anti-rat IgG, 1/2000 dilution (Santa Cruz Biotechnology, Santa Cruz, CA)). Secondary Abs were diluted in PBS containing 5% nonfat milk and incubated with membranes for 1 h at room temperature. Membranes were washed (five times, 5 min each) with PBST. Binding of secondary Ab was detected with the enhanced chemoluminescence (ECL) detection method (Amersham Life Science, Little Chalfont, U.K.). In some experiments, immunoblots were stripped: membranes were washed for 5 min at room temperature in 5x SSC (0.75 M sodium chloride, 0.075 M sodium citrate, pH 7). Membranes were placed in 0.1x SSC containing 0.1% SDS and incubated for 1 h at 65°C in a water bath with gentle rotation, followed by an additional wash for 5 min at room temperature in 5x SSC. Stripped membranes were blocked and reprobed using an alternate primary Ab, as described above. In blocking experiments, blots were first cut into individual lanes after the initial blocking step and individual strips were incubated overnight at 4°C (or 2 h at room temperature) with one of the following: no Ab, rabbit anti-Taxol (1 µg/ml), rat anti-CD18 (10 µg/ml), or isotype-matched, affinity-purified control Abs (rabbit IgG or rat anti-Mac-3). Blots were washed with PBST and incubated with either rat anti-CD18 (10 µg/ml) or rabbit anti-Taxol (1 µg/ml) primary Ab to detect CD18 or Taxol-cross-linked proteins, respectively.

Primary Abs

Anti-Taxol Ab was generated by hyperimmunizing rabbits with Taxol cross-linked at C7 to keyhole limpet hemocyanin. Polyclonal Abs were ammonium sulfate precipitated, affinity purified by passage over a protein A column, and dialyzed in PBS. For Western analysis, rabbit anti-Taxol Ab was used at a final concentration of 1 µg/ml. The following primary Abs were also used: rabbit anti-BSA antiserum (kindly provided by Dr. Bob Roberson, University of Maryland, College Park, MD; 1:1500), rabbit anti-murine CD14 antiserum (kindly provided by Dr. Richard Ulevitch, Scripps Research, La Jolla, CA; 1:400), and rat anti-mouse CD18 Ab, GAME 46 (34) (kindly provided by Dr. Ed Roos, The Netherlands Cancer Institute, Amsterdam; 5 µg/ml).

Preparation of Taxol-cross-linked proteins for liquid chromatography quadropole (LCQ) analysis

PA Taxol-cross-linked membrane proteins (600 µg) were resolved on a 9% preparative SDS-PAGE, and a single lane from each edge of the gel was excised and processed for Western analysis to detect Taxol-bound proteins (see above). The remaining gel was stained with 0.1% Coomassie blue in 10% acetic acid, 50% methanol for 30 min. The gel was destained for >=2 h in 10% acetic acid, 50% methanol until the background was clear. The polyvinylidene difluoride membrane strips that were developed with anti-Taxol Ab were positioned next to the Coomassie-stained gel. The region on the stained gel that coincided positionally with the ~96-kDa species was excised. A blank gel piece was excised as a control. Gel slices were placed in Eppendorf tubes, frozen, and sent to the W. M. Keck Foundation (New Haven, CT) for LCQ analysis. Briefly, 32 pmol of the ~96-kDa gel slice was digested with trypsin, along with the blank gel slice. Approximately 10% of the digest was subjected to LC-MS/MS using an LCQ ion trap mass spectrometer (35). A Sequest search of the OWL database indicated that one of the reconstructed MS/MS spectra had significant similarity (i.e., the difference in the normalized cross-correlation functions as defined by Eng et al. (36) of the first and second ranked searches was 0.32) to the observed spectra. This reconstructed spectra corresponded to an 18-residue peptide, SAVGELSDDSSNVVQLIK, found in mouse cell surface adhesion glycoproteins (LFA-1, CR3, and P150, 95, ß subunit precursor), preceded by a lysine.

Other reagents

Recombinant human soluble CD14 (sCD14) and recombinant murine soluble CD14 (mu sCD14) were kindly provided by Dr. Henri Lichenstein (Amgen Boulder, Boulder, CO) and Dr. Christine Schütt (Arndt-Universität Greifswald, Greifswald, Germany), respectively. Tubulin, devoid of microtubule-associated proteins, was isolated from calf brain, as described (37). Affinity-purified rabbit IgG was kindly provided by Dr. Mark Lynch (Bristol-Myers Squibb, Princeton, NJ). Rat anti-Mac-3 (IgG1) was affinity purified from the M3/84 myeloma cell line (American Type Culture Collection (ATCC), Manassas, VA; TIB168). Affinity-purified rat anti-Mac-1 (IgG2b; M1/70; ATCC; TIB 128) and isotype-matched control (anti-CD122; PharMingen, San Diego, CA) Abs were used in IL-12 secretion experiments. Taxol was provided by the Drug Synthesis and Chemistry Branch (National Institutes of Health), and Escherichia coli K235 LPS was prepared by the method of McIntire et al. (38).

Analysis of IL-12 p40 mRNA and IL-12 p70 secretion

IL-12 p40 mRNA was measured by quantitative RT-PCR, using hypoxanthine-guanine phosphoribosyltransferase (HPRT) as a housekeeping gene (39). Immunoreactive IL-12 p70 was measured by ELISA (PharMingen), following the manufacturer’s instructions.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Use of a photoaffinity-labeled Taxol analogue (PA Taxol) to identify novel Taxol-binding proteins in murine macrophages

To determine whether novel Taxol-binding proteins could be detected in murine macrophage membranes, macrophage membranes were subjected to UV cross-linking in the presence or absence of PA Taxol, an analogue developed to identify the Taxol-microtubule binding domain (23). Fig. 1GoA shows that Taxol-cross-linked C3H/OuJ membranes (XL C3H/OuJ), but not uncross-linked membranes (C3H/OuJ), show a distinct pattern of immunoreactive bands when detected by Western analysis with a primary rabbit anti-Taxol Ab (RaTaxol); bands were not detected in the presence of secondary Ab only (GaR), or if an irrelevant primary Ab, rabbit anti-BSA, were used. Inclusion of 50 µM Taxol at the time of the incubation of the blot with anti-Taxol Ab resulted in nearly complete competition of all bands (data not shown). The seven major species detected in 9–10% polyacrylamide gels migrate with average molecular mass of 197 kDa, 149 kDa (sometimes resolvable as a doublet), 114 kDa, 96 kDa (always the major species that appears as a broad band), 80 kDa, 56 kDa, and 53 kDa (also sometimes resolvable as a doublet). Bands detected by Western analysis did not coincide with major bands seen after Coomassie staining (data not shown). In certain experiments, an additional centrifugation step was included after UV cross-linking. Ninety percent of the total membrane protein subjected to cross-linking remained in the supernatant, with an enrichment of the 114-, 96-, and 80-kDa species. These species are presumably associated with membrane microdomains that remain soluble following UV cross-linking, in contrast to those recovered in the pellet fraction. All major species were detected in the pellet fraction (data not shown).



View larger version (43K):
[in this window]
[in a new window]
 
FIGURE 1. Detection of PA Taxol-cross-linked proteins in murine macrophage membranes. A, C3H/OuJ macrophage membranes were UV cross-linked (XL) in the presence of 100 µM PA Taxol, and subjected to SDS-PAGE and then Western analysis using rabbit anti-Taxol (RaTx) or rabbit anti-BSA (RaBSA) as primary Abs and GaR as the secondary Ab. B, C3H/OuJ macrophage membranes were UV cross-linked (XL) in the presence of underivatized Taxol (100 µM) or PA Taxol (10 or 100 µM), and subjected to SDS-PAGE and Western analysis using rabbit anti-Taxol (RaTx) as the primary Ab and GaR as the secondary Ab. C, C3H/OuJ and C3H/HeJ macrophage membranes were UV cross-linked (XL) in the presence of 100 µM PA Taxol, and subjected to SDS-PAGE and then Western blot analysis using rabbit anti-Taxol (RaTaxol) as the primary Ab and GaR as the secondary Ab. A total of 30 µg protein/lane was analyzed using 9% SDS-PAGE gels in all panels. Dots indicate the position of the major PA Taxol-cross-linked species. Molecular masses of marker proteins are indicated in kilodaltons (KD). Results are representative of two to five separate experiments.

 
Earlier studies have shown that [3H]Taxol could be UV cross-linked to ß-tubulin without PA derivitization (32) and that binding of a PA Taxol analogue similar to that used in these studies could be competed by underivatized Taxol (40). Therefore, macrophage membranes were UV cross-linked in the presence of underivatized Taxol or PA Taxol (Fig. 1GoB). Under our standard conditions in which PA Taxol was used at 100 µM (i.e., similar to those used in studies with ß-tubulin) (40), the seven major immunoreactive species were readily detected. A total of 10 µM PA Taxol resulted in less intense bands, although positionally indistinguishable from those detected after cross-linking with 100 µM PA Taxol. Underivatized Taxol, used at a 100 µM, also resulted in detection of the same immunoreactive species, although the efficiency of cross-linking was much more like that seen with the suboptimal (10 µM) concentration of PA Taxol. These data support the hypothesis that the PA Taxol interacts with the same major membrane proteins as underivatized Taxol.

C3H/HeJ mice express a gene defect (Lpsd) that renders them refractory to LPS in vivo and in vitro (reviewed in 41). A point mutation in the intracytoplasmic domain of the TLR4 transmembrane receptor underlies this defect (42). Since Taxol has been shown to act only on macrophages that possess normal LPS responsiveness (Lpsn), and not in C3H/HeJ macrophages (4), membranes from C3H/OuJ (Lpsn) and C3H/HeJ (Lpsd) mice were subjected to UV cross-linking with PA Taxol. Fig. 1GoC shows no obvious differences in the pattern of immunoreactive species in Western blots derived from the two mouse strains. Collectively, the data in Fig. 1Go, A–C, illustrate the specificity and reproducibility of the detection system.

Membrane CD14, ~53–56 kDa molecular mass, is the major LPS-binding protein on macrophages (reviewed in 43). Studies using macrophages from CD14 knockout mice showed a CD14 dependency for Taxol stimulation, albeit more limited than observed for LPS (22). Therefore, we tested the hypothesis that either the 53- or 56-kDa Taxol-binding proteins were CD14. Murine sCD14 failed to be cross-linked by PA Taxol, under conditions in which the 53- and 56-kDa Taxol-cross-linked species were detected in the C3H/OuJ membrane preparation (Fig. 2Go). Similarly, no anti-Taxol immunoreactive bands were detected in cross-linked human sCD14, under conditions in which tubulin was extensively cross-linked and readily detected by Western analysis (i.e., it formed high m.w. complexes). Thus, CD14 is not a target for Taxol binding.



View larger version (60K):
[in this window]
[in a new window]
 
FIGURE 2. PA Taxol cross-linking of murine soluble CD14 (mu sCD14). Mu sCD14 (10 µg) or C3H/OuJ macrophage membranes were UV cross-linked (XL) in the presence of PA Taxol or not (no modifier), and were subjected to 10% SDS-PAGE and Western analysis with anti-Taxol or anti-CD14 Ab, as described for Fig. 1Go. Results are representative of three separate experiments.

 
Taxol cross-linking to various membrane preparations

An analysis of membrane preparations derived from several LPS-responsive cell lines was undertaken to evaluate the potential for common Taxol-binding proteins. Fig. 3Go compares PA Taxol-cross-linked membranes derived from CHO cells that express human CD11b/CD18, SAM8 (murine CD14 transfectant), and the control CHO-NEO cell line, the murine ST2 cell line, and C3H/OuJ and C3H/HeJ macrophages. Both the CD11b/CD18 and SAM8 transfectants respond to rough LPS (29, 30), but not to Taxol (unpublished observations); the control CHO-NEO cell line responds to neither LPS nor Taxol. The murine ST2 cell line, derived from bone marrow stromal cells (28), responds to both LPS and Taxol (29). C3H/OuJ (LPS- and Taxol-responsive) and C3H/HeJ (LPS- and Taxol-hyporesponsive) macrophage membranes were included as controls. Western analysis of PA Taxol-cross-linked membranes from the three CHO cell lines was indistinguishable, but exhibited a pattern of anti-Taxol immunoreactive bands distinct from that exhibited by the ST2 cell line, and from the pattern common to C3H/OuJ and C3H/HeJ macrophage membranes. A number of bands comigrate in all of the membranes, including those with apparent molecular mass of ~149 kDa, ~114 kDa (although considerably fainter in the macrophage membranes), ~80 kDa, and ~53 kDa (the latter was somewhat more prominently detected in the macrophage membranes), and the ~56-kDa species is more pronounced in the ST2 cell line. Most significantly, the ~96-kDa species appears to be predominant and specific to the murine macrophage membrane preparations.



View larger version (60K):
[in this window]
[in a new window]
 
FIGURE 3. Detection of PA Taxol-cross-linked proteins in membranes prepared from CHO cell transfectants (human CD11b/CD18 (CHO-huCD11b/CD18), murine CD14 (CHO-SAM8), and control (CHO-NEO)), murine ST2 stromal cells, and murine C3H/OuJ and C3H/HeJ macrophages. SDS-PAGE and Western analysis were conducted as described for Fig. 1Go. Results are representative of five separate experiments.

 
Identification of the major Taxol-binding species in murine macrophages as CD18

LCQ analysis of peptides derived from the preparative ~96-kDa gel slice indicated that the mass/charge ratio of one tryptic fragment was derived from murine CD18, the common ß-chain of the ß2 family of integrins (reviewed in 44). CD18 is expressed as an obligate {alpha}ß heterodimer in noncovalent association with CD11a, CD11b, CD11c, or CD11d (reviewed in 44). Since CD11b/CD18 (also referred to as Mac-1) is the predominant ß2 integrin on murine macrophages (reviewed in Refs. 44 and 45), and since CD11b/CD18 has been found to mediate LPS signaling in macrophages and in CHO cells transfected with human CD11b/CD18 (31), we tested the hypothesis that the ~96-kDa Taxol-binding protein was CD18. To address this possibility, we took advantage of mice with a targeted mutation in CD11b, the {alpha} subunit of Mac-1 (24). Previous FACS analysis revealed that neutrophils and macrophages derived from CD11b knockout mice lack surface CD11b (24) and that surface expression of CD18 on thioglycollate-elicited macrophages was reduced by >85% (Coxon and Mayadas, unpublished). This observation is consistent with finding that CD11b/CD18 is the most abundant ß2 integrin on macrophages (45), and that in the absence of {alpha} subunits, CD18 is not translocated to the cell surface (reviewed in 44). Thus, we reasoned that if CD18 were the predominant Taxol-binding protein in murine macrophages, there should be a significant reduction in the expression of the ~96-kDa Taxol-binding protein in macrophage membranes derived from CD11b knockout mice.

Fig. 4Go shows the results of two separate experiments in which membranes from CD11b (Mac-1) knockout macrophages and background-matched, wild-type macrophages were compared for their ability to be UV cross-linked with PA Taxol. As a control, C3H/OuJ membranes were included. First, noncross-linked (Expt. 1) or PA Taxol-cross-linked (Expt. 2) Mac-1 (+/+), Mac-1 (-/-), and C3H/OuJ membranes were subjected to SDS-PAGE analysis in the absence of DTT (-DTT), conditions that are required for Western analysis with anti-CD18 mAb (i.e., the anti-murine CD18 is directed against a conformational epitope, precluding its use under reducing conditions) (34). Our experiments show that the membranes of Mac-1 knockout macrophages are highly deficient in two immunoreactive species that are present in both the Mac-1 (+/+) and C3H/OuJ membranes, supporting the prediction that surface expression of CD18 is diminished in Mac-1-deficient macrophages. A comparison of the first panel in each of the two experiments also indicates that Taxol cross-linking does not alter detection of these immunoreactive species by Western blot analysis. The second panel in each experiment represents the identical blot used to detect CD18 that was stripped and reprobed with anti-Taxol Ab. In experiment 1, no signal is detected in the stripped blot because the membranes were not PA Taxol cross-linked; however, in experiment 2, the PA Taxol-cross-linked Mac-1 (-/-) membranes (-DTT) demonstrate a markedly reduced signal that corresponds positionally to the species detected with anti-CD18. When these same PA Taxol-cross-linked membrane preparations were compared using our standard reducing conditions (+DTT) and Western analysis with the anti-Taxol Ab (the third panel in both experiments), the signal corresponding to the ~96-kDa species, present as the major species in both the Mac-1 (+/+) and C3H/OuJ membranes, was greatly diminished in macrophage membranes derived from the Mac-1 (-/-) mice. These data support the hypothesis that the predominant Taxol-binding protein in the murine macrophage membranes is CD18. Careful analysis of the Western blots that were conducted after size fractionation of membrane components under reducing conditions reveals that, in addition to the major ~96-kDa species being depreciated in intensity, the Mac-1 (-/-) preparations showed a reduced signal for several other proteins (e.g., the doublet at ~53 and 56 kDa), under conditions in which the intensity of the ~80-kDa species is indistinguishable.



View larger version (36K):
[in this window]
[in a new window]
 
FIGURE 4. Detection of CD18 and PA Taxol-cross-linked proteins in membranes derived from Mac-1 (+/+), Mac-1 (-/-), and C3H/OuJ macrophages. Macrophage membranes were UV cross-linked in the presence of PA Taxol (XL) or not (no modifier), and subjected to SDS-PAGE under nonreducing (-DTT) or reducing (+DTT) conditions, then subjected to Western analysis. Results are representative of six separate experiments.

 
To confirm that CD18 is the major Taxol-binding protein, competition experiments were conducted to block detection of CD18 in the Western analysis using anti-Taxol Ab as the blocking agent, and conversely, to block detection of the ~96-kDa Taxol-substituted protein with anti-CD18 Ab (Fig. 5Go). Western analysis of PA Taxol-cross-linked C3H/OuJ membranes, subjected to SDS-PAGE under nonreducing conditions, revealed that rabbit anti-Taxol, but not rabbit IgG, blocked the capacity of rat anti-CD18 to detect immunoreactive species. Conversely, when rat anti-CD18 was used as the blocking agent, a significant inhibition of detection using anti-Taxol Ab was observed.



View larger version (34K):
[in this window]
[in a new window]
 
FIGURE 5. Anti-Taxol Ab blocks detection of CD18, and anti-CD18 Ab blocks detection of the Taxol-cross-linked ~96-kDa species in PA Taxol-cross-linked C3H/OuJ membranes. C3H/OuJ macrophage membranes were UV cross-linked in the presence of 100 µM PA Taxol and subjected to SDS-PAGE under nonreducing conditions (-DTT). Western analysis was conducted using rat anti-CD18 (rat a CD18) or rabbit anti-Taxol (RaTx) following incubation of individual lanes in the absence or presence of blocking Abs or their isotype-matched controls (indicated above each lane), as described in Materials and Methods. Results are representative of two separate experiments.

 
Mac-1 knockout macrophages exhibit diminished IL-12 p40 mRNA induction in response to Taxol and LPS

Sutterwala et al. (46) recently showed that induction of IL-12 p40 mRNA in murine bone marrow macrophages by LPS was reduced significantly by cross-linking Mac-1 on the cell surface. To determine whether Taxol-induced IL-12 p40 mRNA was also Mac-1 dependent, Mac-1 (+/+) and Mac-1 knockout (-/-) macrophages were stimulated with various concentrations of Taxol or with LPS. Fig. 6Go shows that IL-12 p40 mRNA was strongly induced in control macrophages at all concentrations of Taxol, and equivalently to a dose of LPS shown previously to induce suboptimal expression of this gene (39). In contrast, Mac-1 knockout macrophages responded only minimally to 5 and 10 µM Taxol, and less well than +/+ macrophages at higher concentrations of Taxol or to LPS, under conditions of comparable expression of the housekeeping gene, HPRT. These data demonstrate a Mac-1 dependency for both LPS- and Taxol-induced IL-12 p40 mRNA expression.



View larger version (26K):
[in this window]
[in a new window]
 
FIGURE 6. Induction of IL-12 p40 mRNA by Taxol and LPS in macrophages derived from Mac-1 (+/+) and Mac-1 (-/-) mice. Macrophages were plated at a final concentration of 6.5 x 106 cells/well in six-well culture plates and treated for 4 h with the indicated concentration of Taxol or LPS. Total RNA was harvested and subjected to quantitative RT-PCR, as described previously (39). HPRT was included as the housekeeping gene. This Southern blot is representative of three separate experiments.

 
Anti-Mac-1 Ab blocks both LPS- and Taxol-elicited IL-12 p70 secretion in C3H/OuJ macrophages

Functional IL-12 exists as a protein heterodimer (IL-12 p70), composed of proteins derived from both the IL-12 p40 and IL-12 p35 genes. Therefore, we analyzed the capacity of anti-Mac-1 Abs to block Taxol-induced IL-12 secretion. Table IGo illustrates that both Taxol- and LPS-induced IL-12 p70 secretion is markedly reduced in macrophages treated with anti-Mac-1 Ab versus macrophages treated with either medium or an isotype-matched control Ab.


View this table:
[in this window]
[in a new window]
 
Table I. Effect of anti-Mac-1 or control Ab on LPS- and Taxol-induced IL-12 p70 secretion in C3H/OuJ macrophages1

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Taxol is best known for its antitumor activity, which is affected by its ability to interact with ß-tubulin to hyperstabilize microtubules and block mitosis. However, Taxol is a full LPS mimetic in murine macrophages, an activity that is mechanistically distinct from its ß-tubulin-binding activity. Based on the observation that LPS analogue antagonists block the LPS-mimetic effects of Taxol, we hypothesized that Taxol’s LPS-mimetic activity was due to its interaction with a membrane structure(s) distinct from ß-tubulin within a putative LPS receptor complex that engages signal transduction pathways common to both LPS and Taxol. To date, identification of proteins within an LPS signaling complex has been fraught with technical difficulties due to the extremely hydrophobic nature of LPS-derived probes. To obviate this concern, we used a novel, photoactivatable Taxol analogue (PA Taxol), used originally in studies of Taxol’s interaction with microtubule proteins, to cross-link components of this putative, common signaling complex within murine macrophage membranes. We sought to identify structures associated with Taxol-induced proinflammatory actions in murine macrophages that might ultimately lead to the identification of homologous human proteins involved in LPS signaling. We found that PA Taxol binds to a number of proteins in cell membranes in a reproducible and specific fashion, in addition to its well-characterized ability to interact with ß-tubulin in the context of microtubules.

A comparison of the electrophoretic mobilities of Taxol-bound proteins with those of binding or signaling proteins previously implicated in LPS signaling permitted us to exclude a number of obvious candidate proteins, e.g., lyn (53 and 56 kDa), hck (56 and 59 kDa), fgr (59 kDa), c-raf (74 kDa), P13-kinase (85 kDa), rsk (90 kDa), vav (95 kDa), Sos 1, 2 (170 kDa), and other molecules (e.g., monomeric ß-tubulin), by their failure to comigrate with Taxol-cross-linked species (data not shown). CD14, the best-characterized macrophage LPS receptor, was also excluded, since 1) neither murine nor human sCD14 could be PA Taxol cross-linked (Fig. 2Go); 2) CHO cells that overexpress murine CD14 failed to exhibit an augmented signal in this molecular mass range upon cross-linking and Western analysis with anti-Taxol Ab (Fig. 3Go); and, 3) Taxol-binding patterns of macrophage membranes from C57BL/6J, background-matched CD14 knockout, and C3H mice were indistinguishable (data not shown). However, the key finding of a comparison of membranes derived from several LPS-responsive cell lines is that macrophage membranes exhibit a major Taxol-binding protein at ~96 kDa, not seen in the other five membrane preparations. Peptide analysis of the ~96-kDa preparative gel slice indicated the presence of CD18, a molecule previously implicated in LPS signaling in the context of ß2 integrin expression in macrophages and neutrophils (reviewed in 47). Fig. 4Go confirms that the Mac-1 knockout macrophages possess markedly decreased amounts of immunoreactive CD18, a concordant loss of a major Taxol-binding species with similar electrophoretic mobility under nonreducing conditions, and a massive diminution of the major ~96-kDa Taxol-binding protein under reducing conditions. The results of Fig. 5Go suggest that the epitope recognized by the anti-CD18 Ab and substituted by Taxol on CD18 must be in close physical proximity. Thus, the major Taxol-binding protein in murine macrophages is CD18. The failure of the LPS-responsive CHO human CD11b/CD18 transfectant to exhibit a prominent Taxol-cross-linked ~96-kDa band (Fig. 3Go), coupled with its lack of Taxol sensitivity to induce NF-{kappa}B translocation (data not shown), suggests a possible basis for the species specificity of Taxol for murine macrophages.

Although Mac-1 was shown many years ago to recognize LPS and Gram-negative bacteria (48), it is only within the past few years that evidence has been provided for its role in LPS-induced signal transduction. Ikeda et al. (49) demonstrated that anti-CD18 Ab blocked acute lethality in LPS-injected, Propionibacterium acnes-primed rabbits, accompanied by a decrease in plasma cytokine levels. Direct evidence came from the creation of CHO cell transfectants that expressed either human CD11c/CD18 or CD11b/CD18 (31, 50), that were responsive to stimulation by rough LPS to induce NF-{kappa}B translocation. Stimulation of these cell lines required significantly more LPS than CD14-CHO transfectants (30), but did not require sCD14 or LPS-binding protein. Fig. 6Go and Table IGo show that both Taxol- and LPS-induced IL-12 p40 gene expression and IL-12 p70 secretion in mouse are Mac-1 dependent, particularly at lower Taxol concentrations, and support the findings of Sutterwala et al. (46), who showed that ligation of Mac-1 severely limits induction of IL-12 p40 mRNA by LPS. That higher concentrations of Taxol, as well as LPS, induce suboptimal IL-12 p40 gene expression in Mac-1 knockout macrophages suggests the possibility of additional Taxol- or LPS-binding proteins. This notion is also supported by the observation that the Taxol-responsive ST-2 line (29) failed to express the ~96-kDa Taxol-binding protein (Fig. 3Go).

Ingalls et al. found that the cytoplasmic domains of CD11b and CD18 could be severely truncated, yet retain their ability to serve as LPS receptors in CHO cell transfectants (31), supporting the notion that Mac-1 presents LPS to a second signaling receptor for NF-{kappa}B translocation. In this regard, recent studies have shown that cells cotransfected with CD14 and TLR2 constructs exhibited greater NF-{kappa}B translocation induced by LPS than observed in cells transfected with TLR2 only (51, 52). This suggests that CD14, which is GPI linked and has no signaling capability of its own, presents LPS to a TLR for signaling. Perhaps, analogously, TLR molecules serve as signal-transducing molecules for Taxol presented by Mac-1 following its binding to CD18. Our finding that there is no detectable difference in the Taxol-binding patterns exhibited by Lpsn or Lpsd macrophages (Figs. 1Go and 3Go) is consistent with the widely held hypothesis that the C3H/HeJ defect, recently identified as a single amino acid change in the intracytoplasmic domain of TLR4 (42), is distal to receptor/ligand interaction at the surface of the membrane (reviewed in 41). Since certain normal LPS-induced signaling events have been observed in C3H/HeJ macrophages within the first few minutes of LPS or Taxol stimulation (5; reviewed in 41), the failure of C3H/HeJ macrophages to respond to both LPS and Taxol is most likely due to an interruption in the signal transduction machinery shared by these two stimuli.

Zarewych et al. (53) demonstrated a transient association of CD14 and Mac-1 on human neutrophils that was observed in the presence of LPS and serum or LPS-binding protein. Additional studies (reviewed in 47) suggest that the physical interaction of ß2 integrins with GPI-linked proteins, including CD14, urokinase plasminogen activator, and Fc{gamma}RIIIB, may enable signal transduction to occur in response to engagement of the GPI-linked protein with its specific ligand (i.e., LPS, in the case of CD14). In this model, the primary interaction of LPS with CD14 would lead to a transient association with a ß2 integrin, such as Mac-1, that in turn would initiate signaling through the activation of the G protein, rho, and the assemblage of an intracellular platform that includes protein kinase C, protein tyrosine kinases, and mitogen-activated protein kinases, components previously implicated in LPS signaling (reviewed in 54). Using gentle immunoprecipitation that resulted in recovery of Mac-1/urokinase plasminogen activator complexes, as well as associated src family kinases (55), Petty et al. (56) found five proteins associated with Mac-1 with estimated molecular mass of 40, 50, 74, and 120 kDa, in addition to the Mac-1 {alpha}- and ß-chains. Careful examination of Fig. 5Go revealed that not only was the ~96-kDa Taxol-binding protein largely absent in the Mac-1 knockout membranes, but there also was a concomitant disappearance of the ~53- and ~56-kDa species. It is tempting to speculate that these are components of the signaling pathway normally associated with Mac-1. Hence, one could envision a model in which both CD14 and Mac-1 are brought together following interaction of CD14 with LPS or of Mac-1 with Taxol or LPS to engage signaling components, such as TLR molecules, and/or to activate additional signaling pathways through Mac-1. This model also accounts for the observation that CD14-mediated LPS signaling, CD11/CD18-mediated LPS signaling (57), and Taxol signaling are blocked by LPS analogue antagonists. Previous studies support the hypothesis that these antagonists act at sites distinct from CD14 or Mac-1 (30, 58). Since TLR2 binds LPS (51), the LPS analogue antagonists may also bind the same signal-transducing molecule, and thereby inhibit intracellular signaling components normally activated by LPS or Taxol. Thus, it is possible that LPS and Taxol are inhibited by these compounds, despite the fact that they bind initially to distinct pattern recognition receptors (59).

At this time, the identities of the other major Taxol-cross-linked species are unknown. However, an ~80-kDa LPS receptor was first identified by Morrison and colleagues (reviewed in 21) in murine and human macrophages using a photoaffinity-labeled, 125I-labeled LPS analogue. mAb raised against this molecule induced LPS-like signaling. Dziarski (60) later suggested that this molecule was murine albumin. In this regard, our ~80-kDa Taxol-binding protein was completely separable from bovine, murine, and human albumins, based on clearly differing electrophoretic mobilities after Western blot analysis with anti-Taxol versus anti-BSA Abs (data not shown). Schletter et al. identified an ~80-kDa LPS-binding protein as the GPI-linked protein, decay-accelerating factor, in human macrophage membranes (61, 62). It is tempting to speculate that our ~80-kDa Taxol-cross-linked protein might represent one of these. We are continuing to approach the identification of each of these novel Taxol targets by a combination of biochemical, immunologic, and genetic approaches, as demonstrated herein for the identification of the ~96-kDa species as CD18.


    Acknowledgments
 
We thank Sheila Hauck and Dr. Vittorio Farina for the conjugation of BSA and keyhole limpet hemocyanin to Taxol as well as the many people who generously provided reagents for this study: Drs. Bob S. Roberson, Richard Ulevitch, Ed Roos, Henri Lichenstein, Christine Schütt, and Mark Lynch. Finally, we appreciate the advice of Drs. S. Shaw and E. Roos during the preparation of this manuscript.


    Footnotes
 
1 This work was supported by National Institutes of Health Grants AI-18797 (S.N.V.), NS-33296 (T.N.M.), GM-54060, and AI-38515 (D.T.G.). Back

2 N.B. and P.-Y.P. contributed equally to the work presented in this study. Back

3 Address correspondence and reprint requests to Dr. Stefanie N. Vogel, Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814. E-mail address: Back

4 Abbreviations used in this paper: CHO, Chinese hamster ovary; GaR, goat anti-rabbit IgG Ab; HPRT, hypoxanthine-guanine phosphoribosyltransferase; LCQ, liquid chromatography quadropole; PA, photoactivatable; PBST, PBS + Tween (0.05%); sCD14, soluble CD14; TLR, Toll-like receptor. Back

Received for publication July 17, 1998. Accepted for publication March 24, 1999.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Horwitz, S. B.. 1994. Taxol (paclitaxel): mechanisms of action. Ann. Oncol. 5:(Suppl. 6):S3.[Abstract]
  2. Manthey, C. L., S. N. Vogel. 1994. Taxol: a promising endotoxin research tool. J. Endotoxin Res. 1:189.[Abstract/Free Full Text]
  3. Ding, A. H., F. Porteu, E. Sanchez, C. F. Nathan. 1990. Down-regulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents. J. Exp. Med. 171:715.[Abstract/Free Full Text]
  4. Ding, A., F. Porteu, E. Sanchez, C. F. Nathan. 1990. Shared actions of endotoxin and Taxol on TNF receptors and TNF release. Science 248:370.[Abstract/Free Full Text]
  5. Henricson, B. E., J. M. Carboni, A. L. Burkhardt, S. N. Vogel. 1995. LPS and Taxol activate Lyn kinase autophosphorylation in Lpsn, but not in Lpsd, macrophages. Mol. Med. 1:428.[Medline]
  6. Wolfson, M., C. P. Wang, S. B. Horwitz. 1997. Taxol induces tyrosine phosphorylation of Shc and its association with Grb2 in murine RAW 264.7 cells. Int. J. Cancer 70:248.[Medline]
  7. Manthey, C. L., M. E. Brandes, P.-Y. Perera, S. N. Vogel. 1992. Taxol increases steady-state levels of LPS-inducible genes and protein-tyrosine phosphorylation in murine macrophages. J. Immunol. 149:2459.[Abstract]
  8. Bogden, C., A. Ding. 1992. Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor {alpha} and interleukin-1 in macrophages. J. Leukocyte Biol. 52:119.[Abstract]
  9. Carboni, J. M., C. Singh, M. A. Tepper. 1993. Taxol and lipopolysaccharide activation of a murine macrophage cell line and induction of similar tyrosine phosphoproteins. Monogr. Natl. Cancer Inst. 15:95.
  10. Ding, A., E. Sanchez, C. Nathan. 1993. Taxol shares the ability of bacterial lipopolysaccharide to induce tyrosine phosphorylation of microtubule-associated protein kinase. J. Immunol. 151:5596.[Abstract]
  11. Perera, P.-Y., N. Qureshi, S. N. Vogel. 1996. Paclitaxel (Taxol)-induced NF-{kappa}B translocation in murine macrophages. Infect. Immun. 64:878.[Abstract]
  12. Hwang, S., A. Ding. 1995. Activation of NF-{kappa}B in murine macrophages by Taxol. Cancer Biochem. Biophys. 14:265.[Medline]
  13. Manthey, C. L., P.-Y. Perera, C. A. Salkowski, S. N. Vogel. 1994. Taxol provides a second signal for murine macrophage tumoricidal activity. J. Immunol. 152:825.[Abstract]
  14. Doherty, T. M., A. Sher, S. N. Vogel. 1998. Paclitaxel (Taxol)-induced killing of Leishmania major in murine macrophages. Infect. Immun. 66:4553.[Abstract/Free Full Text]
  15. Manthey, C. L., N. Qureshi, P. L. Stütz, S. N. Vogel. 1993. Lipopolysaccharide antagonists block Taxol-induced signaling in murine macrophages. J. Exp. Med. 178:695.[Abstract/Free Full Text]
  16. Vogel, S. N., J. M. Carboni, C. L. Manthey. 1995. Paclitaxel, a mimetic of bacterial lipopolysaccharide (LPS) in murine macrophages. T. T. Chen, and I. Ojima, and D. M. Vyas, eds. Taxane Anticancer Agents Basic Science and Current Status, Ch. 12 162. American Chemical Society, Washington, D.C.
  17. Kirikae, T., I. Ojima, F. Kirikae, Z. Ma, S. D. Kudu, J. C. Slater, C. S. Takeuchi, P.-Y. Bounaud, M. Nakano. 1996. Structural requirements of taxoids for nitric oxide and tumor necrosis factor production by murine macrophages. Biochem. Biophys. Res. Commun. 227:227.[Medline]
  18. Moos, P. J., F. A. Fitzpatrick. 1998. Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoptosis. Proc. Natl. Acad. Sci. USA 95:3896.[Abstract/Free Full Text]
  19. Muhlradt, P. F., F. Sasse. 1997. Epothilone B stabilizes microtubuli of macrophages like Taxol without showing Taxol-like endotoxin activity. Cancer Res. 57:3344.[Abstract/Free Full Text]
  20. Morrison, D. C., D. M. Jacobs. 1976. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 13:813.[Medline]
  21. Morrison, D. C.. 1990. Diversity of mammalian macromolecules which bind to bacterial lipopolysaccharide. A. Nowotny, and J. J. Spitzer, and E. J. Zigler, eds. Cellular and Molecular Aspects of Endotoxin Reactions 183.-189. Excerpta Medica, Amsterdam.
  22. Perera, P.-Y., S. N. Vogel, G. R. Detore, A. Haziot, S. M. Goyert. 1997. CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 "knockout" mice stimulated with LPS or Taxol. J. Immunol. 158:4422.[Abstract]
  23. Carboni, J. M., V. Farina, S. Rao, S. I. Hauck, S. B. Horwitz, I. Ringel. 1993. Synthesis of a photoaffinity analog of Taxol as an approach to identify the Taxol binding site on microtubules. J. Med. Chem. 36:513.[Medline]
  24. Coxon, A., P. Rieu, F. J. Barkalow, S. Askari, A. H. Sharpe, U. H. von Andrian, M. A. Arnaout, T. N. Mayadas. 1996. A novel role for the ß2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 5:653.[Medline]
  25. Jesaitis, A. J., J. R. Naemura, R. G. Painter, L. A. Sklar, C. G. Cochrane. 1982. Intracellular localization of N-formyl chemotactic receptor and Mg2+ dependent-ATPase in human granulocytes. Biochem. Biophys. Acta 719:556.[Medline]
  26. Sambrook, J., E. F. Fritsch, T. Maniatis. 1989. Molecular Cloning, a Lab Manual 2nd Ed.18.34.. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
  27. Liu, J., S. Mathias, Z. Yang, R. N. Kolesnick. 1994. Renaturation and tumor necrosis factor-{alpha} stimulation of a 97-kDa ceramide-activated protein kinase. J. Biol. Chem. 269:3047.[Abstract/Free Full Text]
  28. Nishikawa, S.-I., M. Ogawa, S. Nishikawa, T. Kunisada, H. Kodama. 1988. B lymphopoiesis on stromal cell clone: stromal cell clones acting on different stages of B cell differentiation. Eur. J. Immunol. 18:1767.[Medline]
  29. Kirikae, T., F. Kirikae, K. Tominaga, N. Qureshi, J. S. Yamamoto, M. Nakano. 1997. Rhodobacter sphaeroides diphosphoryl lipid A inhibits interleukin-6 production in CD14-negative murine marrow stromal ST2 cells stimulated with lipopolysaccharide or paclitaxel (Taxol). J. Endotoxin Res. 4:115.[Abstract/Free Full Text]
  30. DeLude, R. L., R. Savedra, H. Zhao, R. Thieringer, S. Yamamoto, M. J. Fenton, D. T. Golenbock. 1995. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc. Natl. Acad. Sci. USA 92:9288.[Abstract/Free Full Text]
  31. Ingalls, R. R., M. A. Arnaout, D. T. Golenbock. 1997. Outside-in signaling by LPS through a tailless integrin. J. Immunol. 159:433.[Abstract]
  32. Rao, S., S. B. Horwitz, I. Ringle. 1992. Direct photoaffinity labelling of tubulin with Taxol. J. Natl. Cancer Inst. 84:785.[Abstract/Free Full Text]
  33. Laemmli, U. K.. 1970. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227:680.[Medline]
  34. Driessens, M. H. E., P. van Hulten, A. Zuurbier, G. La Riviere, E. Roos. 1996. Inhibition and stimulation of LFA-1 and Mac-1 functions by antibodies against murine CD18: evidence that the LFA-1 binding sites for ICAM-1, -2, and -3 are distinct. J. Leukocyte Biol. 60:758.[Abstract]
  35. Stone, K. L., R. DeAngelis, M. LoPresti, J. Jones, V. Papov, and K. Williams. 1998. Protein identification by MS/MS spectral analysis of enzymatically digested SDS-PAGE separated proteins. Electrophoresis. In press.
  36. Eng, J., A. McCormack, J. Yates. 1994. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5:976.
  37. Williams, R. C., J. C. Lee. 1982. Preparation of tubulin from brain. Motility Apparatus in Nonmuscle Cells, Ch. 36 376. Academic Press, New York.
  38. McIntire, F. C., H. W. Dievert, G. H. Barlow, R. A. Finley, W. Y. Lee. 1967. Chemical, physical, and biological properties of lipopolysaccharide from Escherichia coli K-235. Biochemistry 6:2363.[Medline]
  39. Salkowski, C. A., G. R. Detore, S. N. Vogel. 1997. Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, {gamma} interferon, and interleukin-10 mRNA production in murine macrophages. Infect. Immun. 65:3239.[Abstract]
  40. Rao, S., G. A. Orr, A. G. Chaudhary, D. G. I. Kingston, S. B. Horwitz. 1995. Characterization of the Taxol binding site on the microtubule. 2-(m-azidobenzoyl) Taxol photolabels a peptide (amino acids 217–231) of ß-tubulin. J. Biol. Chem. 270:20235.[Abstract/Free Full Text]
  41. Vogel, S. N., N. Bhat, S. T. Qureshi, D. Malo. 1998. Genetic control of endotoxin responsiveness: the Lps gene revisited. D. C. Morrison, and H. Brade, and S. M. Opal, and S. N. Vogel, eds. Endotoxin in Health and Disease Marcel Dekker, New York.
  42. Poltorak, A., X. He, I. Smirnova, M.-Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in tlr4 gene. Science 282:2085.[Abstract/Free Full Text]
  43. Rietschel, E. T., H. Brade, O. Holst, L. Brade, S. Müller-Loennies, U. Mamat, U. Zähringer, F. Bechmann, U. Seydel, K. Brandenburg, et al 1996. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr. Top. Microbiol. Immunol. 216:39.[Medline]
  44. Arnaout, M. A.. 1990. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 75:1037.[Free Full Text]
  45. Lau, W., J. M. Devery, C. L. Geczy. 1995. A chemotactic S100 peptide enhances scavenger receptor and Mac-1 expression and cholesteryl ester accumulation in murine peritoneal macrophages in vitro. J. Clin. Invest. 95:1957.
  46. Sutterwala, F. S., G. J. Noel, R. Clynes, D. M. Mosser. 1998. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 185:1977.[Abstract/Free Full Text]
  47. Petty, H. R., R. F. Todd. 1996. Integrins as promiscuous signal transduction devices. Immunol. Today 17:209.[Medline]
  48. Wright, S. D., M. T. C. Jong. 1986. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J. Exp. Med. 164:1876.[Abstract/Free Full Text]
  49. Ikeda, N., N. Mukaida, S. Knaeko, N. Fujioka, S.-B. Su, H. Nariuchi, M. Unoura, K.-I. Harada, Y. Nakanuma, K.-I. Kobayashi, K. Matsushima. 1995. Prevention of endotoxin-induced acute lethality in Propionibacterium acnes-primed rabbits by an antibody to leukocyte integrin ß2 with concomitant reduction of cytokine production. Infect. Immun. 63:4812.[Abstract]
  50. Ingalls, R. R., D. T. Golenbock. 1995. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J. Exp. Med. 181:1473.[Abstract/Free Full Text]
  51. Yang, R.-B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard. W. I. Wood, A. L. Gurney, P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284.[Medline]
  52. Kirschning, C. J., H. Wesche, T. M. Ayers, M. Rothe. 1998. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188:2091.[Abstract/Free Full Text]
  53. Zarewych, D. M., A. L. Kindzelskii, R. F. Todd, H. R. Petty. 1996. LPS induces CD14 association with complement receptor type 3, which is reversed by neutrophil adhesion. J. Immunol. 156:430.[Abstract]
  54. Schwartz, M. A., M. D. Schaller, M. H. Ginsberg. 1995. Integrins: emerging paradigms of signal transduction. Annu. Rev. Cell. Dev. Biol. 11:549.[Medline]
  55. Bohuslav, J., V. Horejsi, C. Hansmann, J. Stöckl, U. H. Weidle, O. Majdic, I. Bartke, W. Knapp, H. Stockinger. 1995. Urokinase plasminogen activator receptor, ß2 integrins, and src-kinases within a single complex of human monocytes. J. Exp. Med. 181:1381.[Abstract/Free Full Text]
  56. Petty, H. R., A. L. Kindzelskii, Y. Adachi, R. F. Todd. 1997. Ectodomain interactions of leukocyte integrins and pro-inflammatory GPI-linked membrane proteins. J. Pharmacol. Biomed. Anal. 15:1405.
  57. Ingalls, R. R., B. Monks, R. Savedra, W. J. Christ, R. L. Delude, A. E. Medvedev, T. Espevik, D. T. Golenbock. 1998. CD11/CD18 and CD14 share a common lipid A signaling pathway. J. Immunol. 161:5413.[Abstract/Free Full Text]
  58. Kitchens, R. L., R. J. Ulevitch, R. S. Munford. 1992. Lipopolysaccharide (LPS) partial structures inhibit responses of LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J. Exp. Med. 176:485.[Abstract/Free Full Text]
  59. Pugin, J., D. Heuman, A. Tomasaz, V. V. Kravchenko, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunology 1:509.
  60. Dziarski, R.. 1994. Cell-bound albumin is the 70-kDa peptidoglycan-, lipopolysaccharide-, and lipoteichoic acid-binding protein on lymphocytes and macrophages. J. Biol. Chem. 269:20431.[Abstract/Free Full Text]
  61. Schletter, J., H. Brade, L. Brade, C. Kruger, H. Loppnow, S. Kusumoto, E. T. Reitschel, H.-D. Flad, A. J. Ulmer. 1995. Binding of lipopolysaccharide (LPS) to an 80-kilodalton membrane protein of human cells is mediated by soluble CD14 and LPS-binding protein. Infect. Immun. 63:2576.[Abstract]
  62. Hamann, L., V. T. El-Samalouti, J. Schletter, I. Chyla, A. Lentschat, H. D. Flad, E. Th. Rietschel, and A. J. Ulmer. 1998. CD55, a new LPS-signaling element. In The Fifth Conference of the International Endotoxin Society. Santa Fe, NM, (Poster Abstr. 61). J Endotoxin Research (in press).



This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
C.-S. Lin, J. G. Wann, C.-W. Hsiao, D. W. Tai, J.-S. Chen, Y.-H. Hsu, H.-C. Huang, and C.-F. Chao
Intracellular acidification enhances neutrophil phagocytosis in chronic haemodialysis patients: possible role of CD11b/CD18
Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1642 - 1649.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. J. Sheedy and L. A. J. O'Neill
The Troll in Toll: Mal and Tram as bridges for TLR2 and TLR4 signaling
J. Leukoc. Biol., August 1, 2007; 82(2): 196 - 203.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. A. Costa and D. I. Simon
Molecular Basis of Restenosis and Drug-Eluting Stents
Circulation, May 3, 2005; 111(17): 2257 - 2273.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Nakayama, S. Okugawa, S. Yanagimoto, T. Kitazawa, K. Tsukada, M. Kawada, S. Kimura, K. Hirai, Y. Takagaki, and Y. Ota
Involvement of IRAK-M in Peptidoglycan-induced Tolerance in Macrophages
J. Biol. Chem., February 20, 2004; 279(8): 6629 - 6634.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
O. Levy, R. M. Jean-Jacques, C. Cywes, R. B. Sisson, K. A. Zarember, P. J. Godowski, J. L. Christianson, H.-K. Guttormsen, M. C. Carroll, A. Nicholson-Weller, et al.
Critical Role of the Complement System in Group B Streptococcus-Induced Tumor Necrosis Factor Alpha Release
Infect. Immun., November 1, 2003; 71(11): 6344 - 6353.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Qureshi, P.-Y. Perera, J. Shen, G. Zhang, A. Lenschat, G. Splitter, D. C. Morrison, and S. N. Vogel
The Proteasome as a Lipopolysaccharide-Binding Protein in Macrophages: Differential Effects of Proteasome Inhibition on Lipopolysaccharide-Induced Signaling Events
J. Immunol., August 1, 2003; 171(3): 1515 - 1525.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. E. Medvedev, A. Lentschat, L. M. Wahl, D. T. Golenbock, and S. N. Vogel
Dysregulation of LPS-Induced Toll-Like Receptor 4-MyD88 Complex Formation and IL-1 Receptor-Associated Kinase 1 Activation in Endotoxin-Tolerant Cells
J. Immunol., November 1, 2002; 169(9): 5209 - 5216.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Henneke, O. Takeuchi, R. Malley, E. Lien, R. R. Ingalls, M. W. Freeman, T. Mayadas, V. Nizet, S. Akira, D. L. Kasper, et al.
Cellular Activation, Phagocytosis, and Bactericidal Activity Against Group B Streptococcus Involve Parallel Myeloid Differentiation Factor 88-Dependent and Independent Signaling Pathways
J. Immunol., October 1, 2002; 169(7): 3970 - 3977.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
M A Moscarello, B Mak, T A Nguyen, D D Wood, F Mastronardi, and S K Ludwin
Paclitaxel (Taxol) attenuates clinical disease in a spontaneously demyelinating transgenic mouse and induces remyelination
Multiple Sclerosis, April 1, 2002; 8(2): 130 - 138.
[Abstract] [PDF]


Home page
Clin. Cancer Res.Home page
P. B. Cassidy, P. J. Moos, R. C. Kelly, and F. A. Fitzpatrick
Cyclooxygenase-2 Induction by Paclitaxel, Docetaxel, and Taxane Analogues in Human Monocytes and Murine Macrophages: Structure-Activity Relationships and Their Implications
Clin. Cancer Res., March 1, 2002; 8(3): 846 - 855.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
S. H. Diks, S. J.H. van Deventer, and M. P. Peppelenbosch
Invited review: Lipopolysaccharide recognition, internalisation, signalling and other cellular effects
Innate Immunity, October 1, 2001; 7(5): 335 - 348.
[Abstract] [PDF]


Home page
Innate ImmunityHome page
B. Beutler, Xin Du, and A. Poltorak
Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies
Innate Immunity, August 1, 2001; 7(4): 277 - 280.
[PDF]


Home page
Innate ImmunityHome page
K. Kawasaki, S. Akashi, R. Shimazu, T. Yoshida, K. Miyake, and M. Nishijima
Involvement of TLR4/MD-2 complex in species-specific lipopolysaccharide-mimetic signal transduction by Taxol
Innate Immunity, June 1, 2001; 7(3): 232 - 236.
[Abstract] [PDF]


Home page
Innate ImmunityHome page
S. Vogel, M. J. Hirschfeld, and P.-Y. Perera
Signal integration in lipopolysaccharide (LPS)-stimulated murine macrophages
Innate Immunity, June 1, 2001; 7(3): 237 - 241.
[Abstract] [PDF]


Home page
J. Immunol.Home page
T. K. Means, B. W. Jones, A. B. Schromm, B. A. Shurtleff, J. A. Smith, J. Keane, D. T. Golenbock, S. N. Vogel, and M. J. Fenton
Differential Effects of a Toll-Like Receptor Antagonist on Mycobacterium tuberculosis-Induced Macrophage Responses
J. Immunol., March 15, 2001; 166(6): 4074 - 4082.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Lee and Y. J. Jeon
Paclitaxel-Induced Immune Suppression Is Associated with NF-{kappa}B Activation Via Conventional PKC Isotypes in Lipopolysaccharide-Stimulated 70Z/3 Pre-B Lymphocyte Tumor Cells
Mol. Pharmacol., February 1, 2001; 59(2): 248 - 253.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
P.-Y. Perera, T. N. Mayadas, O. Takeuchi, S. Akira, M. Zaks-Zilberman, S. M. Goyert, and S. N. Vogel
CD11b/CD18 Acts in Concert with CD14 and Toll-Like Receptor (TLR) 4 to Elicit Full Lipopolysaccharide and Taxol-Inducible Gene Expression
J. Immunol., January 1, 2001; 166(1): 574 - 581.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. E. Drachman, E. R. Edelman, P. Seifert, A. R. Groothuis, D. A. Bornstein, K. R. Kamath, M. Palasis, D. Yang, S. H. Nott, and C. Rogers
Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2325 - 2332.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. J. Moore, L. P. Andersson, R. R. Ingalls, B. G. Monks, R. Li, M. A. Arnaout, D. T. Golenbock, and M. W. Freeman
Divergent Response to LPS and Bacteria in CD14-Deficient Murine Macrophages
J. Immunol., October 15, 2000; 165(8): 4272 - 4280.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
P. Matthys, K. Vermeire, H. Heremans, and A. Billiau
The protective effect of IFN-{gamma} in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis
J. Leukoc. Biol., October 1, 2000; 68(4): 447 - 454.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
C.-P. H. Yang and S. B. Horwitz
Taxol Mediates Serine Phosphorylation of the 66-kDa Shc Isoform
Cancer Res., September 1, 2000; 60(18): 5171 - 5178.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Kawasaki, S. Akashi, R. Shimazu, T. Yoshida, K. Miyake, and M. Nishijima
Mouse Toll-like Receptor 4{middle dot}MD-2 Complex Mediates Lipopolysaccharide-mimetic Signal Transduction by Taxol
J. Biol. Chem., January 28, 2000; 275(4): 2251 - 2254.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
P.-Y. Perera, J. F. Kadow, C. R. Fairchild, K. A. Johnston, and S. N. Vogel
Analysis of structure activity relationships for LPS-mimetic activities of taxane analogs in murine macrophages
Innate Immunity, October 1, 1999; 5(5-6): 261 - 267.
[Abstract] [PDF]


Home page
J. Immunol.Home page
T. K. Means, S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, and M. J. Fenton
Human Toll-Like Receptors Mediate Cellular Activation by Mycobacterium tuberculosis
J. Immunol., October 1, 1999; 163(7): 3920 - 3927.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
S. N. Vogel, N. Bhat, J. M. Carboni, T. N. Mayadas, J. Blanco, P.-Y. Perera, and D. T. Golenbock
Identification of CD18 as a novel Taxol binding/signaling protein in murine macrophage membranes
Innate Immunity, June 1, 1999; 5(3): 170 - 173.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
J.-i. Okano and A. K. Rustgi
Paclitaxel Induces Prolonged Activation of the Ras/MEK/ERK Pathway Independently of Activating the Programmed Cell Death Machinery
J. Biol. Chem., May 25, 2001; 276(22): 19555 - 19564.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhat, N.
Right arrow Articles by Vogel, S. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhat, N.
Right arrow Articles by Vogel, S. N.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS